Cassava Sciences agreed to pay $31.25 million to settle a securities class action tied to investors from 2020 to 2023, with no admission of wrongdoing.
Cassava Sciences agreed to pay $31.25 million to settle a securities class action tied to investors from 2020 to 2023, with no admission of wrongdoing.